For more than a decade, IRICoR, a Centre of Excellence in Commercialization and Research specializing in drug discovery, has become a key player in the life sciences field. It plays an increasingly pivotal role in developing new therapies for cancer and for rare diseases.
IRICoR’s mission is to facilitate and accelerate the transformation of research results into innovation for the benefit of patients. The organization sets itself apart by providing strategic support at every step of the drug discovery process leading to the commercialization of innovative therapeutic solutions.
IRICoR, a world leader in drug discovery to fight cancer and rare diseases.